The facade of the City Hall will be lit up in blue on the occasion of International Angelman Syndrome Day
El Parc Taulí is one of the centers of reference for the diagnosis and follow-up of these patients from all over Spain. read more
Angelman syndrome
Parc Taulí participates in an international trial to improve the symptoms of patients with Angelman syndrome
The Parc Taulí Paediatrics Service has been participating, since last August, in an international clinical trial that aims to reverse the expression of the genetic defect of children with Angelman syndrome, which could lead to an important improvement in the symptomatology of patients diagnosed with this minority disease. This is a project promoted by the pharmaceutical company F. Hoffman-La Roche, which will have about 60 patients from all over the world, including 3 patients from Parc Taulí, with the intention of incorporating ne 3 more over the next few months. read more